Imaging techniques for non-invasive assessment of coronary heart disease in hypertension: Value of an integrated approach

Journal of Hypertension

Volumn 19, Issue 4, 2001, Pages 679-682

  De Simone, Giovanni ^a,b,c   Parati, Gianfranco ^a,b,c  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Coronary heart disease; Essential hypertension; Myocardial scintigraphy; Stress echocardiography; Stress testing

Indexed keywords

DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY;

EID: 0035073960     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200104000-00003     Document Type: Review

References (25)

1. Prevalence and natural history of electrocardiographic left ventricular hypertrophy
2. Ambulatory blood pressure monitoring and organ damage
3. The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure
4. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
5. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events
6. Evaluation of organ damage in hypertension
7. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
8. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
9. Prognostic value of serial changes in left ventricular mass in essential hypertension
10. Left ventricular mass as a measure of preclinical hypertensive disease
11. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle
12. Comparison of the prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease
13. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: A prospective, largescale, multicenter, head-to-head comparison between dipyridamole and dobutamine test
14. Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre. Experience in 1082 patients
15. Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardiac risk stratification in vascular surgery patients
16. Dipyridamole-atropine stress echocardiography versus exercise SPECT Scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test
17. The atropine factor in pharmacologic stress echocardiography
18. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing)
19. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment
20. Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function
21. Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: A report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies
22. Dipyridamole-echocardiography test in essential hypertensives with chest pain and angiographically normal coronary arteries
23. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension
24. Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools
25. The extraction of Thallium-201 by the myocardium